Trials / Conditions / Camrelizumab
Camrelizumab
7 registered clinical trials studyying Camrelizumab — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma NCT06485466 | Guohui Xu | Phase 3 |
| Recruiting | bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC NCT06061276 | Sun Yat-sen University | N/A |
| Not Yet Recruiting | A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Adva NCT06276933 | Tongji University | Phase 4 |
| Recruiting | Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast NCT05475678 | Zhenzhen Liu | Phase 2 |
| Recruiting | Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma NCT05512481 | Peking University Cancer Hospital & Institute | Phase 2 |
| Unknown | H101 Combined With Camrelizumab for Recurrent Cervical Cancer NCT05234905 | Zhejiang Cancer Hospital | Phase 2 |
| Unknown | Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuse NCT05114707 | Sun Yat-sen University | Phase 2 |